socalTECH

JANUARY 29, 2021

San Diego-based Encodia, a biotech company which is focused on proteomics research, has raised $75M in a Series C funding round, the company said this week.

San Diego 113

San Diego Research Capital Funding 113

socalTECH

NOVEMBER 10, 2020

San Diego-based biopharmaceuticals developer Ambrx has raised $200M in a funding round, according to the company, which included Fidelity Management & Research Company LLC, funds and accounts managed by BlackRock, Cormorant Asset Management, HBM Healthcare Investments, Invus, Adage Capital Partners and Suvretta Capital Management.

San Diego 113

San Diego Research Capital Invest 113

socalTECH

JULY 20, 2021

San Diego-based Wugen, a biotechnology company which is developing treatments for solid tumors, recently annoucned a $172M, Series B funding round. Managing Partner at Abingworth, Bosun Hau, Managing Director at Tybourne Capital Management, and Peter Kiener, Ph.D., Bali Muralidhar, M.D., Bali Muralidhar, M.D.,

San Diego 113

San Diego Capital Research Platform 113

socalTECH

MARCH 29, 2021

San Diego-based Fortis Therapeutics, a biotechnology startup developing treatments for late-stage prostate cancer and multiple myeloma, has raised $40M in a Series A financing, the company said on Monday.

Avalon 113

Avalon San Diego Research Funding 113

socalTECH

JANUARY 19, 2016

San Diego-based life sciences maker Illumina has participated in another investment round for San Francisco-based DNA synthesis startup Twist Bioscience , in a new Series D funding for that company. Nick and Joby Pritzker (via Tao Invest), Paladin Capital Group, Yuri Milner, Boris Nikolic, plus others.

Invest 100

Invest San Diego Research Capital 100

socalTECH

AUGUST 5, 2021

San Diego-based Aardvark Therapeutics, a biopharmaceuticals company focused on metabolic diseases, said this morning that it has raised $29M in its Series B funding round. The company said the funding will go towards three Phase 2 clinical trails of its lead compound, and to advance several potential additional formulations.

San Diego 140

San Diego Research Funding Invest 140

socalTECH

DECEMBER 30, 2016

Here, we have the thoughts of Jeb Spencer of TVC Capital (www.tvccapital.com), a software focused growth equity fund, and has had some great success in the market. TVC Capital has also been a big supporter and sponsor of socaltech over the years. An interesting investment for our firm, the $16.5 READ MORE>>.

Capital 113

Capital Southern California Equity San Diego 113

socalTECH

OCTOBER 29, 2019

San Diego-based Boundless Bio , the biopharmaceuticals startup which recently raised $46M for treating aggressive cancers , has named Christian ("Chris") Hassig, Ph.D., as its Chief Scientific Officer. READ MORE>>.

San Diego 100

San Diego Research Capital Invest 100

Xconomy

MARCH 13, 2018

In the Boston office of GE Ventures, managing director Alex de Winter is overseeing investments in companies like Veracyte, which is applying machine learning to genomic sequencing technology to help doctors distinguish benign growths from cancer. Read more » Reprints | Share: UNDERWRITERS AND PARTNERS.

San Diego 67

San Diego Artificial Inteligence Research Invest 67

socalTECH

APRIL 29, 2010

Schrodinger , a firm focused on computational drug design for the pharmaceuticals and biotechnology research industry, announced today that Bill Gates--through his investment firm, Cascade Investment--has invested in the company. Schrodinger is spread between Portland, New York, San Diego, and Cambridge, Massachusetts.

Invest 140

Invest San Diego Design Research 140

socalTECH

SEPTEMBER 19, 2008

Venture capital firm Sofinnova Ventures has hired on an Executive-in-Residence based in San Diego, the firm said Thursday. Sofinnova, which invests in early stage life sciences and IT firms, said it has appointed Lars Ekman, M.D., Ekman is te former EVP and President of Global Research and Development at Elan Corporation.

San Diego 100

San Diego Venture Capital Research Capital 100

socalTECH

JANUARY 8, 2021

San Diego-based Blacksmith Medicines, a new biotechnology company focused on creating medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, has raised a round of seed funding, and announced a research deal with Lilly. Financial details of that seed funding were not announced.

Seed Funding 113

Seed Funding Funding San Diego Research 113

socalTECH

JULY 16, 2019

San Diego-based Trefoil Therapeutics , which is developing treatments for corneal diseases, has raised $28M in its Series A funding, the company said on Tuesday. joins the company's board; Robertson was formerly vice president in Research & Development at Alcon Laboratories. Robertson, Ph.D.,

San Diego 113

San Diego Research Funding Capital 113

socalTECH

SEPTEMBER 10, 2014

San Diego-based Avelas Biosciences , which is developing cell penetrating peptides to light up cancerous tissue in patients during surgery, has raised $7.4M The second tranche of the company''s Series B came from investors Avalon Ventures, Torrey Pines Investment and WuXi PharmaTech Investments. in a Series B funding.

Avalon 147

Avalon San Diego Venture Capital Research 147

Xconomy

SEPTEMBER 5, 2017

To that end, Kukutai’s venture capital firm, Finistere Ventures, is joining with the Ireland Strategic Investment Fund to launch a new 20 million euro ($24 million) fund that will invest in emerging agtech startups in Ireland.

Invest 88

Invest Funding San Diego Venture Capital 88

socalTECH

FEBRUARY 23, 2011

San Diego-based Biomatrica , a developer of technology for storing biological samples at room temperature, announced this morning that it has scored an investment from In-Q-Tel, the investment arm of the U.S. In-Q-Tel is the investment arm of the CIA and other intelligence agencies. intelligence community.

Invest 160

Invest Sample San Diego Research 160

socalTECH

SEPTEMBER 5, 2018

San Diego-based Gossamer Bio , the biopharmaceuticals firm which is focused on therapeutics in the autoimmune, allergy/inflammation and immuno-oncology disease areas, said today that it has named Luisa Salter-Cid, Ph.D. , Gossamer Bio said Salter-Cid will head up research and preclinical development efforts at the company.

San Diego 100

San Diego Research Funding Invest 100

socalTECH

JUNE 9, 2015

San Diego-based life sciences equipment maker Illumina is the lead investor in San Francisco-based Twist Bioscience , a developer of a synthetic DNA manufacturing technology. Twist Bioscience said it raised $37M in a Series C, led by Illumina, and also included Fidelity Management and Research Company. in venture funding.

San Diego 100

San Diego Research Capital Invest 100

socalTECH

APRIL 4, 2011

San Diego-based AnaBios , a contract research organization focused on drug safety, said today that it has raised $800,000 as part of a Series A funding round. The funding was led by the Tech Coast Angels, including the Tech Coast Angels Angel Capital Entrepreneur (ACE) fund. AnaBios is headed by Dr. Jack A.

Tech Coast Angels 133

Tech Coast Angels San Diego Research Organization 133

Xconomy

JULY 17, 2020

If it seems like biotech investments have defied the financial headwinds of the pandemic, maybe it’s because they have. In the second quarter, 16 of the top 25 largest early-stage venture capital deals were investments in life science companies. It’s the biotech sector’s largest proportion of the top 25.

Venture Capital 90

Venture Capital Invest Research Capital 90

socalTECH

AUGUST 18, 2010

San Diego-based Anametrix , a developer of cloud-based business analytics software, said today that it has received new funding and added a slate of well known advisors. Details on the new private investment was not disclosed. Senturia is CEO of Blackbird Ventures, and a notable San Diego angel investor.

SEM 174

SEM Funding San Diego SaaS 174

Xconomy

MARCH 13, 2018

Crinetics Pharmaceuticals , a San Diego biotech focused on developing new drugs for endocrine disorders and endocrine-related cancers, said today it has raised $63.5 Two new investors, RA Capital and OrbiMed, joined the round, along with existing investors 5AM Ventures, Versant Ventures, and Vivo Capital.

San Diego 49

San Diego Research Funding Capital 49

socalTECH

SEPTEMBER 21, 2011

San Diego-based MeLLmo , the developer of the Roambi mobile business apps, said today that it has launched a new iPad App, Roambi Flow. The firm--which is fresh off a $30M funding from Sequoia Capital--said the new software allows users to view "magazine-style" reports and publications on the iPad. READ MORE>>.

San Diego 140

San Diego Report Research Mobile 140

socalTECH

NOVEMBER 13, 2012

San Diego-based Epic Sciences , a firm developing cancer diagnostics technology, announced today that it has raised $13M in a Series B equity round. The round came from Domain Associates, Roche Venture Fund, and Pfizer Venture Investments, along with individuals. Kim Kamdar of Domain joins the company's board with the funding.

San Diego 138

San Diego Research Equity Platform 138

socalTECH

NOVEMBER 4, 2009

For this morning's interview, we sat down with Dr. Alfred Wong , Chief Science Officer, and Albert Liu , Vice President of Business Development, at Pong Research (www.pongresearch.com), a company developing products for redirecting cell phone antennas to reduce the radiation exposure of users. Talk about the technology behind the product?

Research 138

Research UCLA Design Product 138

Xconomy

OCTOBER 1, 2018

VelosBio, a biotech startup researching new cancer drugs, has raised $58 million in financing. VelosBio joined Johnson & Johnson’s JLABS @ San Diego incubator in January. The new VelosBio cash, a Series A round of financing, was led by Arix Bioscience (LSE: ARIX ) and Sofinnova Ventures.

San Diego 91

San Diego Incubator Class Study 91

socalTECH

JUNE 18, 2012

San Diego-based SmartDrive Systems , which develops driving safety systems for managing driving fleets, said Monday afternoon that it has raised $47m in a new funding round. The firm said the round was led by Oak Investment Partners and New Enterprise Associates, and also included Stanford University. READ MORE>>.

Veoh 150

Veoh San Diego Research Funding 150

Xconomy

JUNE 22, 2016

Radicle, which takes its name from the botany term for the part of a plant embryo that develops into the primary root, was founded by a mix of agricultural investment and industry heavyweights. Before making an investment, Radicle says it screens technologies and can quickly vet and validate technologies through its farm connections.

Funding 68

Funding Research San Diego Incubator 68

socalTECH

MARCH 8, 2011

San Diego-based Sapphire Energy , a developer of algae-based biofuels technology, has scored an investment and deal with agricultural chemicals firm Monsanto , the two said this morning. Financial details of the investment were not disclosed. Sapphire has also scored $104.5M Sapphire has also scored $104.5M

San Diego 145

San Diego Equity Research Invest 145

socalTECH

OCTOBER 7, 2010

A new report released today by Next 10 , a nonprofit, nonpartisan public policy group, says that Southern California--and California, as a whole--leads the green innovation, cleantech venture capital, and energy market. The report was compiled by research firm Colaborative Economics.

Southern California 165

Southern California Report Orange County Patents 165

Xconomy

APRIL 30, 2019

Vividion Therapeutics, a biotechnology company that launched in 2017 around discoveries made in Scripps Research Institute labs, has raised $82 million in financing. Nextech Invest, a Swiss investment firm that funds companies developing cancer therapeutics, led the Series B round of funding.

Research 87

Research Invest Funding Develop 87

Xconomy

AUGUST 17, 2016

Histogen, a San Diego-based regenerative medicine company with technology for growing skin cells and related products, said it has raised $6 million from an affiliate of Huapont Life Sciences, a healthcare products company based in Chongqing, China.

Invest 40

Invest San Diego Journal Technical Review 40

TechCrunch LA

APRIL 8, 2021

In a small industrial park located nearly halfway between Los Angeles and San Diego, one company is claiming to have hit a milestone in the development of a new technology for generating power from nuclear fusion. Vulcan, Venrock, NEA, Wellcome Trust, Google, and the Kuwait Investment Authority are all backers.

Technology 354

Technology Artificial Inteligence Google Orange County 354

Xconomy

FEBRUARY 15, 2017

For these reasons, fatty liver disease is often called a “silent disease,” says Ariel Feldstein, a gastroenterologist at the University of California San Diego. Feldstein has been studying the liver for nearly 20 years, and his research now forms the basis of a newly launched company called Jecure Therapeutics.

UCSD 64

UCSD Press San Diego Class 64

Xconomy

SEPTEMBER 5, 2018

Los Angeles has long been in San Francisco’s shadow when it comes to life sciences investment. But a new venture capital firm led by industry veterans is trying to cast the City of Angels in a new light. Westlake Village BioPartners is launching today with $350 million in committed capital.

Westlake Village 73

Westlake Village Los Angeles Angel Venture Capital 73

Both Sides of the Table

APRIL 27, 2013

Just ask the people of Portland, Seattle, Boulder, Iowa, Princeton, Dallas or countless other cities that don’t have enough venture capital. If you don’t live in a major VC zone, I have some tips for how to make it easier to raise Venture Capital. But I do invest outside of LA. Ask SuperCell. Or UrbanAirship.

Venture Capital 365

Venture Capital Marketing Santa Barbara Startup 365

Xconomy

OCTOBER 1, 2019

Biologists have been using artificially created DNA, produced through what’s known as chemical DNA synthesis, as a research tool for decades. Now, as demand for engineered DNA rises, a handful of startups are vying to become the go-to provider for researchers looking for improved versions of the DNA sequences.

San Diego 43

San Diego Research Writing Demand 43